CORRIGENDUM
SLE and Serum Complement: Causative, Concomitant or Coincidental?
Vaneet Sandhu1, Michele Quan2, *
Article Information
Identifiers and Pagination:
Year: 2018Volume: 12
First Page: 171
Last Page: 171
Publisher ID: TORJ-12-171
DOI: 10.2174/1874312901812010171
Article History:
Electronic publication date: 18/09/2018Collection year: 2018
open-access license: This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: (https://creativecommons.org/licenses/by/4.0/legalcode). This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
SLE and Serum Complement: Causative, Concomitant or Coincidental?
The Open Rheumatology Journal, 2017, 11: 113-122
The revised last paragraph of conclusion in abstract is mentioned below:
It is clinically important to find novel ways to assess disease activity in SLE. Increased serum levels of cell-bound complement activation products may more accurately reflect disease activity than conventional serum C3 and C4 monitoring.
The original last paragraph of conclusion provided was:
It is clinically important to find novel ways to assess disease activity in SLE. Reduced serum levels of cell-bound complement activation products may more accurately reflect disease activity than conventional serum C3 and C4 monitoring.
The revised last paragraph of conclusion is mentioned below:
With recent studies demonstrating that increased levels of serum cell-bound complement activation products may more accurately reflect disease activity than conventional complement C3 and C4 monitoring, we believe that this is an important area for future SLE research and look forward to further studies on research in the complement in SLE.
The original last paragraph of conclusion provided was:
With recent studies demonstrating that reduced levels of serum cell-bound complement activation products may more accurately reflect disease activity than conventional complement C3 and C4 monitoring, we believe that this is an important area for future SLE research and look forward to further studies on research in the complement in SLE.
